Gillian Woollett, MA, DPhil: Creating a Paradigm Shift in Biosimilar Development
By
Published: | Updated:
Gillian Woollett, MA, DPhil, senior vice president, Avalere Health, discusses how confirming "sufficient likeness" in biosimilar development can and should replace the current "totality of the evidence” approach to biosimilar development.